3 Followers SGX:8YY - Biolidics (SGD 0.26) BIOLIDICS LIMITED
Sector: Health Technology, Industry: Medical Specialties

Add to WatchList


SGD 0.26    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

13 Dec 2019


Overview

13 Dec 2019

52 Wk Range: 0.18 - 0.33

Day's Range: 0.25 - 0.26

Last Volume: 56,700

Current Yield: 0%

Projected Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

13 Dec 2019

Metric 8YY S.Median
Beta 0.64 0.19
VaR 35.16 33.08
E.Shortfall 44.29 44.38
Liquidity 22.15K 12.06K

Fundamental

11 Dec 2019

PE: NA

Market Cap: 63M

Price Over Book: 5.836

Price Over Sales: 38.5

Return On Assets: -70.7%

Return On Equity: NA

NAV Over Price: [Friends Only]

General

CEO: Kwang Ping Lew; Michael B. Paumen, PhD

Founded Year: 2009

Headquarters: Singapore

Shares Outstanding: 242.5M

Security Type: Stock

Useful Links
Homepage

Description

Biolidics Ltd. engages in the research, experimental development, and marketing on biotechnology, life and medical science, and electronics related industrial design services. It operates through the following segments: Technical and Product Development, Global Commercial Channel Management, and Corporate. The Technical and Product Development segment involves identifying and assessing collaboration partners and their technology, provision of technical expertise in revenue generating collaboration projects, and product innovation and improvement. The Global Commercial Channel Management segment deals with the management of global distributorship network and direct customers. The Corporate segment refers to the corporate functions in supporting the operations of the group. The company was founded by Johnson Chen on July 19, 2009 and is headquartered in Singapore.